Skip to main content
Top
Published in: Breast Cancer Research 4/2009

Open Access 01-08-2009 | Research article

Improved breast cancer survival following introduction of an organized mammography screening program among both screened and unscreened women: a population-based cohort study

Authors: Mette Kalager, Tor Haldorsen, Michael Bretthauer, Geir Hoff, Steinar O Thoresen, Hans-Olov Adami

Published in: Breast Cancer Research | Issue 4/2009

Login to get access

Abstract

Introduction

Mammography screening reduces breast cancer mortality through earlier diagnosis but may convey further benefit if screening is associated with optimized treatment through multidisciplinary medical care. In Norway, a national mammography screening program was introduced among women aged 50 to 69 years during 1995/6 to 2004. Also during this time, multidisciplinary breast cancer care units were implemented.

Methods

We constructed three cohorts of breast cancer patients: 1) the pre-program group comprising women diagnosed and treated before mammography screening began in their county of residence, 2) the post-program group comprising women diagnosed and treated through multidisciplinary breast cancer care units in their county but before they had been invited to mammography screening; and 3) the screening group comprising women diagnosed and treated after invitation to screening. We calculated Kaplan-Meier plots and multivariable Cox proportional hazard models.

Results

We studied 41,833 women with breast cancer. The nine-year breast cancer-specific survival rate was 0.66 (95%CI: 0.65 to 0.67) in the pre-program group; 0.72 (95%CI: 0.70 to 0.74) in the post-program group; and 0.84 (95%CI: 0.80 to 0.88) in the screening group. In multivariable analyses, the risk of death from breast cancer was 14% lower in the post-program group than in the pre-program group (hazard ratio 0.86; (95%CI: 0.78 to 0.95, P = 0.003)).

Conclusions

After nine years follow-up, at least 33% of the improved survival is attributable to improved breast cancer management through multidisciplinary medical care.
Appendix
Available only for authorised users
Literature
1.
go back to reference Kamangar F, Dores GM, Anderson WF: Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol. 2006, 24: 2137-2150. 10.1200/JCO.2005.05.2308.CrossRefPubMed Kamangar F, Dores GM, Anderson WF: Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol. 2006, 24: 2137-2150. 10.1200/JCO.2005.05.2308.CrossRefPubMed
3.
go back to reference Early Breast Cancer Trialists' Collaborative Group: Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet. 2005, 365: 1687-1717. 10.1016/S0140-6736(05)66544-0.CrossRef Early Breast Cancer Trialists' Collaborative Group: Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet. 2005, 365: 1687-1717. 10.1016/S0140-6736(05)66544-0.CrossRef
4.
go back to reference Early Breast Cancer Trialists' Collaborative Group: Multi-agent chemotherapy for early breast cancer. Cochrane Database Syst Rev. 2002, CD000487-1 Early Breast Cancer Trialists' Collaborative Group: Multi-agent chemotherapy for early breast cancer. Cochrane Database Syst Rev. 2002, CD000487-1
5.
go back to reference Vervoort MM, Draisma G, Fracheboud J, Poll-Franse van de LV, de Koning HJ: Trends in the usage of adjuvant systemic therapy for breast cancer in the Netherlands and its effect on mortality. Br J Cancer. 2004, 91: 242-247.PubMedPubMedCentral Vervoort MM, Draisma G, Fracheboud J, Poll-Franse van de LV, de Koning HJ: Trends in the usage of adjuvant systemic therapy for breast cancer in the Netherlands and its effect on mortality. Br J Cancer. 2004, 91: 242-247.PubMedPubMedCentral
6.
go back to reference Nystrom L, Andersson L, Bjurstam N, Frisell J, Nordenskjold B, Rutqvist LE: Long term effects of mammography screening: updated overview of the Swedish randomised trials. Lancet. 2002, 359: 909-919. 10.1016/S0140-6736(02)08020-0.CrossRefPubMed Nystrom L, Andersson L, Bjurstam N, Frisell J, Nordenskjold B, Rutqvist LE: Long term effects of mammography screening: updated overview of the Swedish randomised trials. Lancet. 2002, 359: 909-919. 10.1016/S0140-6736(02)08020-0.CrossRefPubMed
7.
go back to reference Olsen AH, Njor SH, Vejborg I, Schwartz W, Dalgaard P, Jensen MB, Tanque UB, Blichert-Toft M, Rank F, Mouridsen H, Lynge E: Breast cancer mortality in Copenhagen after introduction of mammography screening: cohort study. BMJ. 2005, 330: 220-10.1136/bmj.38313.639236.82.CrossRefPubMedPubMedCentral Olsen AH, Njor SH, Vejborg I, Schwartz W, Dalgaard P, Jensen MB, Tanque UB, Blichert-Toft M, Rank F, Mouridsen H, Lynge E: Breast cancer mortality in Copenhagen after introduction of mammography screening: cohort study. BMJ. 2005, 330: 220-10.1136/bmj.38313.639236.82.CrossRefPubMedPubMedCentral
8.
go back to reference Berry DA, Corin KA, Plevritis SK, Fryback DG, Clarke L, Zelen M, Mandelblatt JS, Yakovlev AY, Habbema JD, Feuer EJ: Effect of screening and adjuvant therapy on mortality from breast cancer. N Engl J Med. 2005, 353: 1784-1792. 10.1056/NEJMoa050518.CrossRefPubMed Berry DA, Corin KA, Plevritis SK, Fryback DG, Clarke L, Zelen M, Mandelblatt JS, Yakovlev AY, Habbema JD, Feuer EJ: Effect of screening and adjuvant therapy on mortality from breast cancer. N Engl J Med. 2005, 353: 1784-1792. 10.1056/NEJMoa050518.CrossRefPubMed
9.
go back to reference Tabar L, Yen MF, Vitak B, Chen HH, Smith RA, Duffy SW: Mammography service screening and mortality in breast cancer patients: 20-year follow-up before and after introduction of screening. Lancet. 2003, 361: 1405-1410. 10.1016/S0140-6736(03)13143-1.CrossRefPubMed Tabar L, Yen MF, Vitak B, Chen HH, Smith RA, Duffy SW: Mammography service screening and mortality in breast cancer patients: 20-year follow-up before and after introduction of screening. Lancet. 2003, 361: 1405-1410. 10.1016/S0140-6736(03)13143-1.CrossRefPubMed
11.
go back to reference AJCC 2002: Cancer Staging Handbook. 2002, New York: Springer Verlag, Sixth AJCC 2002: Cancer Staging Handbook. 2002, New York: Springer Verlag, Sixth
12.
go back to reference Norwegian Ministry of Social Affairs. Norwegian Official Report (NOU) No 7: Mammography screening in Norway [Norwegian]. 1987 Norwegian Ministry of Social Affairs. Norwegian Official Report (NOU) No 7: Mammography screening in Norway [Norwegian]. 1987
13.
go back to reference Erzaas A: Quality Assurance Manual of the Norwegian Breast Cancer Screening Program [Norwegian]. 1996, The Cancer Registry of Norway, Oslo, Norway, Erzaas A: Quality Assurance Manual of the Norwegian Breast Cancer Screening Program [Norwegian]. 1996, The Cancer Registry of Norway, Oslo, Norway,
14.
go back to reference Perry N, Broeders M, de Wolf C: European guidelines for quality assurance in breast cancer screening and diagnosis. 1996, Office for official publications of the European Communities (ISBN 92-827-7430-9); Luxembourg, 2 Perry N, Broeders M, de Wolf C: European guidelines for quality assurance in breast cancer screening and diagnosis. 1996, Office for official publications of the European Communities (ISBN 92-827-7430-9); Luxembourg, 2
15.
go back to reference Wang H, Kåresen R, Hervik A, Thoresen S: Mammography screening in Norway: results from the first screening round in four counties and cost effectiveness of a modeled nationwide screening. Cancer Causes Control. 2001, 12: 39-45. 10.1023/A:1008999403069.CrossRefPubMed Wang H, Kåresen R, Hervik A, Thoresen S: Mammography screening in Norway: results from the first screening round in four counties and cost effectiveness of a modeled nationwide screening. Cancer Causes Control. 2001, 12: 39-45. 10.1023/A:1008999403069.CrossRefPubMed
16.
go back to reference Hofvind S, Thoresen S, Langmark F: A pilot study of mammography activity at two private institutions in Norway [Norwegian] Report 1–2006. 2006, The Cancer Registry of Norway, Oslo, Norway Hofvind S, Thoresen S, Langmark F: A pilot study of mammography activity at two private institutions in Norway [Norwegian] Report 1–2006. 2006, The Cancer Registry of Norway, Oslo, Norway
17.
go back to reference Feinstein AR, Sosin DM, Wells CK: The Will Rogers phenomenon. Stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer. N Engl J Med. 1985, 312: 1604-1608.CrossRefPubMed Feinstein AR, Sosin DM, Wells CK: The Will Rogers phenomenon. Stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer. N Engl J Med. 1985, 312: 1604-1608.CrossRefPubMed
18.
go back to reference Stockton D, Davies T, Day N, McCann J: Retrospective study for reasons for improved survival in patients with breast cancer in East Anglia: earlier diagnosis or better treatment?. BMJ. 1997, 314: 472-475.CrossRefPubMedPubMedCentral Stockton D, Davies T, Day N, McCann J: Retrospective study for reasons for improved survival in patients with breast cancer in East Anglia: earlier diagnosis or better treatment?. BMJ. 1997, 314: 472-475.CrossRefPubMedPubMedCentral
19.
20.
go back to reference Veronesi U, Cascinelli N, Mariani L, Greco M, Saccozzi R, Luini A, Aguilar M, Marubini E: Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med. 2002, 347: 1227-1232. 10.1056/NEJMoa020989.CrossRefPubMed Veronesi U, Cascinelli N, Mariani L, Greco M, Saccozzi R, Luini A, Aguilar M, Marubini E: Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med. 2002, 347: 1227-1232. 10.1056/NEJMoa020989.CrossRefPubMed
21.
go back to reference Fisher B, Anderson S, Bryant J, Margolese RG, Deutsch M, Fisher ER, Jeong JH, Wolmark N: Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med. 2002, 347: 1233-1241. 10.1056/NEJMoa022152.CrossRefPubMed Fisher B, Anderson S, Bryant J, Margolese RG, Deutsch M, Fisher ER, Jeong JH, Wolmark N: Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med. 2002, 347: 1233-1241. 10.1056/NEJMoa022152.CrossRefPubMed
22.
go back to reference Veronesi P, Robertson C, Maisonneuve P, Renne G, De Cicco C, De Lucia F, Gennari R: A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N Engl J Med. 2003, 349: 546-553. 10.1056/NEJMoa012782.CrossRefPubMed Veronesi P, Robertson C, Maisonneuve P, Renne G, De Cicco C, De Lucia F, Gennari R: A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N Engl J Med. 2003, 349: 546-553. 10.1056/NEJMoa012782.CrossRefPubMed
23.
go back to reference Gillis CR, Hole DJ: Survival outcome of care by specialist surgeons in breast cancer: a study of 3786 patients in the west of Scotland. BMJ. 1996, 312: 145-148.CrossRefPubMedPubMedCentral Gillis CR, Hole DJ: Survival outcome of care by specialist surgeons in breast cancer: a study of 3786 patients in the west of Scotland. BMJ. 1996, 312: 145-148.CrossRefPubMedPubMedCentral
24.
go back to reference Kingsmore D, Ssemwogerere A, Hole D, Gillis C: Specialisation and breast cancer survival in the screening era. Br J Cancer. 2003, 88: 1708-1712. 10.1038/sj.bjc.6600949.CrossRefPubMedPubMedCentral Kingsmore D, Ssemwogerere A, Hole D, Gillis C: Specialisation and breast cancer survival in the screening era. Br J Cancer. 2003, 88: 1708-1712. 10.1038/sj.bjc.6600949.CrossRefPubMedPubMedCentral
25.
go back to reference Sainsbury R, Haward B, Rider L, Johnston C, Round C: Influence of clinician workload and patterns of treatment on survival from breast cancer. Lancet. 1995, 345: 1265-1270. 10.1016/S0140-6736(95)90924-9.CrossRefPubMed Sainsbury R, Haward B, Rider L, Johnston C, Round C: Influence of clinician workload and patterns of treatment on survival from breast cancer. Lancet. 1995, 345: 1265-1270. 10.1016/S0140-6736(95)90924-9.CrossRefPubMed
26.
go back to reference Blanks RG, Moss SM, McGahan CE, Quinn MJ, Babb PJ: Effect of NHS breast screening programme on mortality from breast cancer in England and Wales, 1990–8: comparison of observed with predicted mortality. BMJ. 2000, 321: 665-669. 10.1136/bmj.321.7262.665.CrossRefPubMedPubMedCentral Blanks RG, Moss SM, McGahan CE, Quinn MJ, Babb PJ: Effect of NHS breast screening programme on mortality from breast cancer in England and Wales, 1990–8: comparison of observed with predicted mortality. BMJ. 2000, 321: 665-669. 10.1136/bmj.321.7262.665.CrossRefPubMedPubMedCentral
Metadata
Title
Improved breast cancer survival following introduction of an organized mammography screening program among both screened and unscreened women: a population-based cohort study
Authors
Mette Kalager
Tor Haldorsen
Michael Bretthauer
Geir Hoff
Steinar O Thoresen
Hans-Olov Adami
Publication date
01-08-2009
Publisher
BioMed Central
Published in
Breast Cancer Research / Issue 4/2009
Electronic ISSN: 1465-542X
DOI
https://doi.org/10.1186/bcr2331

Other articles of this Issue 4/2009

Breast Cancer Research 4/2009 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine